Literature DB >> 19402863

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.

M Keskin1, E Dolar, M Dirican, M Kiyici, Y Yilmaz, S Gurel, S G Nak, S Erdinc, M Gulten.   

Abstract

BACKGROUND: It has been recently reported that serum paraoxonase (PON1) and arylesterase (ARE) activities may be significantly reduced in patients with chronic liver disease. The aim of the study was to investigate the relations between serum PON1 and ARE activities and the degree of liver damage in patients with chronic liver injury.
METHODS: We studied a total of 75 patients with chronic liver disease (50 patients with cirrhosis and 25 patients with chronic hepatitis) and 25 healthy comparison subjects. Baseline and salt-stimulated PON1 and ARE activities were determined in all study participants.
RESULTS: Baseline and stimulated PON1 and ARE activities were significantly lower in patients with chronic liver disease than in controls. Cirrhotic patients in Child-Pugh classes B and C subgroups had significantly reduced PON1 and ARE activities compared with Child-Pugh class A patients (both P-values <0.01). Receiver operating characteristic curve analysis showed that serum ARE activity was the most efficient test for identifying the presence and severity of chronic liver injury.
CONCLUSION: Baseline and stimulated PON1 and ARE activities are reduced in patients with chronic liver disease. Serum ARE activity could be a suitable biomarker for the evaluation of the presence and severity of chronic liver damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402863     DOI: 10.1111/j.1445-5994.2009.01793.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  10 in total

1.  Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection.

Authors:  Fazilet Duygu; Suda Tekin Koruk; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Oxidative Stress and Lipid Peroxidation in the Ischemic Small Intestine: Pathological and Biochemical Evaluation in a Rat model of Superior Mesenteric Ischemia.

Authors:  Ersin G Dumlu; Birkan Bozkurt; Mehmet Tokaç; Gulten Kiyak; Alper B Özkardeş; Merve Ergin; Aylin Yazgan; Mehmet Kılıç
Journal:  Int Surg       Date:  2014 Nov-Dec

3.  Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.

Authors:  Yanxia Jin; Yajun Yang; Yanting Su; Xiangdong Ye; Wei Liu; Qing Yang; Jie Wang; Xiangning Fu; Yongsheng Gong; Hui Sun
Journal:  Glycoconj J       Date:  2019-01-03       Impact factor: 2.916

4.  Serum paraoxonase 1 activity status in patients with liver disorders.

Authors:  Vivekananda Kedage; Manjunatha S Muttigi; Mahesh S Shetty; Renuka Suvarna; Soumya S Rao; Chitralekha Joshi; Mungli Prakash
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

5.  Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma.

Authors:  Hikmet Akkız; Sedef Kuran; Ersin Akgöllü; Oğuz Üsküdar; Aynur Bekar; Süleyman Bayram; Selçuk Yıldırım; Yakup Ülger; Berrin Yalınbaş Kaya; Mahmut Şansal; Ercan Çınar
Journal:  Meta Gene       Date:  2013-10-28

6.  PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.

Authors:  Magdalena P Kasprzak; Maria Iskra; Wacław Majewski; Magdalena Budzyń-Napierała; Bogna Gryszczyńska; Krzysztof Strzyżewski; Jakub Kasprzak
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

7.  Serum biomarkers of oxidative stress in cats with feline infectious peritonitis.

Authors:  F Tecles; M Caldín; A Tvarijonaviciute; D Escribano; S Martínez-Subiela; J J Cerón
Journal:  Res Vet Sci       Date:  2015-02-16       Impact factor: 2.534

8.  Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Nevena Kalezic; Zorana Jelic-Ivanovic; Aleksandra Stefanovic; Ivan Palibrk; Lidija Memon; Zdravko Kalaba; Marina Stojanovic; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

Review 9.  Serum paraoxonase 1 (PON1) measurement: an update.

Authors:  Jose J Ceron; Fernando Tecles; Asta Tvarijonaviciute
Journal:  BMC Vet Res       Date:  2014-03-25       Impact factor: 2.741

10.  Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.

Authors:  Xianjun Lao; Xiaogang Wang; Yanqiong Liu; Yu Lu; Dongmei Yang; Minyan Liu; Xiaolian Zhang; Chengzhi Rong; Xue Qin; Shan Li
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.